The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Elevance Health Inc shares valued at $374,580 were purchased by DeVore Susan D. on Aug 19 ’25. At $312.15 per share, DeVore Susan D. acquired 1,200 shares. The insider’s holdings grew to 3,502 shares worth approximately $1.16 million following the completion of this transaction.
Also, BOUDREAUX GAIL purchased 8,500 shares, netting a total of over 2,438,951 in proceeds. Following the buying of shares at $286.94 each, the insider now holds 151,020 shares.
Before that, Kaye Mark had sold 4,588 shares from its account. In a trade valued at $1,949,074, the EVP & CFO traded Elevance Health Inc shares for $424.82 each. Upon closing the transaction, the insider’s holdings decreased to 4,588 shares, worth approximately $6.31 million.
As published in a research note from Argus on July 21, 2025, Elevance Health Inc [ELV] has been rated down from a Buy to a Hold. Analysts at Leerink Partners downgraded the stock from ‘”an Outperform”‘ to ‘”a Market perform”‘ outlook in a report released in mid July. As of April 15, 2025, Robert W. Baird has decreased its “an Outperform” rating to a “Neutral” for ELV. Earlier on March 17, 2025, Argus upgraded its rating. Their new recommendation was “a Buy” for ELV stock which previously was a “a Hold”.
Analyzing ELV Stock Performance
On last trading session, Elevance Health Inc [NYSE: ELV] rose 2.95% to $332.66. The stock’s lowest price that day was $323.06, but it reached a high of $332.75 in the same session. During the last five days, there has been a surge of approximately 1.92%. Over the course of the year, Elevance Health Inc shares have dropped approximately -36.51%. Shares of the company reached a 52-week high of $458.75 on 04/08/25 and a 52-week low of $273.71 on 08/06/25.
Support And Resistance Levels for Elevance Health Inc (ELV)
According to the 24-hour chart, there is a support level at 326.22, which, if violated, would cause prices to drop to 319.79. In the upper region, resistance lies at 335.93. The next price resistance is at 339.21. RSI (Relative Strength Index) is 63.03 on the 14-day chart, showing neutral technical sentiment.
Is Elevance Health Inc subject to short interest?
Stocks of Elevance Health Inc saw a sharp rise in short interest on 2025-09-15 jumping by 0.52 million shares to 3.68 million. Data from Yahoo Finance shows that the short interest on 2025-08-15 was 3.16 million shares. A jump of 14.15% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 1.71 of the overall float, the days-to-cover ratio (short ratio) jumped to 1.71.
Which companies own the most shares of Elevance Health Inc (ELV)?
In terms of Elevance Health Inc share price expectations, FactSet research, analysts set an average price target of 482.5 in the next 12 months, up nearly 49.33% from the previous closing price of $323.12. Analysts anticipate Elevance Health Inc stock to reach 500 by 2025, with the lowest price target being 465. In spite of this, 12 analysts ranked Elevance Health Inc stock as Buy at the end of 2025. On January 22, 2025, Stephens assigned a price target of “an Equal-weight” to the stock and downgraded coverage with a $440.
